| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.45 | 0.004 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |